The Asia Pacific Kidney Function Tests Market would witness market growth of 8.9% CAGR during the forecast period (2021-2027).
In order to evaluate different aspects of kidney function, there are various kinds of kidney function tests. A kidney function test is carried out to confirm whether the kidneys are filtering waste components very slowly and to check if the kidney is pushing proteins into the urine. Regular kidney function tests could assist in recognizing problems like kidney disease in the initial stages, thereby providing an opportunity to stop the further development of the disease. Urine tests, imaging tests, blood tests, and kidney biopsy are some of the popular kidney function tests.
As per the National Kidney Foundation, approximately 37 million individuals are affected by chronic kidney diseases across the United States and 1 in 3 American adults; around 80 million individuals are vulnerable to develop chronic kidney disease. Moreover, around 3 million individuals around the globe are suffering from End-stage renal disease, and hence the number of patients diagnosed with the disease keeps on increasing at a rapid rate. Economies like Japan, Taiwan, and other Asian countries witnessed the maximum prevalence rate of CKD. The prime catalysts for the growth & demand of kidney function tests are the rising alcohol consumption, growing rates of hypertension, diabetes, and obesity, shift to an inactive lifestyle, and a growing number of supportive governmental initiatives for the notice and treatment of kidney diseases.
The Clearance Test market dominated the Malaysia Kidney Function Tests Market by Product in 2020, thereby, achieving a market value of $5.6 million by 2027. The Blood Tests market is exhibiting a CAGR of 9.5% during (2021 - 2027). Additionally, The Urine Tests market is expected to witness highest CAGR of 11.8% during (2021 - 2027).
Based on Product, the market is segmented into Clearance Test, Blood Tests, Urine Tests, Dilution & Concentration Tests, and Others. Based on End Use, the market is segmented into Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes and others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens AG, Randox Laboratories Limited, Quest Diagnostics, Incorporated, Laboratory Corporation of America holdings, Sysmex Corporation, ACON Laboratories, Inc., and Nova Biomedical Corporation.
Scope of the Study
Market Segments covered in the Report:
• Clearance Test
• Blood Tests
• Urine Tests
• Dilution & Concentration Tests,
By End Use
• Diagnostic Laboratories
• Research Laboratories and Institutes
• South Korea
• Rest of Asia Pacific
• Abbott Laboratories
• Danaher Corporation
• F. Hoffmann-La Roche Ltd.
• Siemens AG
• Randox Laboratories Limited
• Quest Diagnostics, Incorporated
• Laboratory Corporation of America holdings
• Sysmex Corporation
• ACON Laboratories, Inc.
• Nova Biomedical Corporation
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free
Our reports have been used by over 10K customers, including:
The in-vitro diagnostics market in Middle East and Africa is expected to grow from US$ 2,675.1 million in 2019 to US$ 3,454.0 million by 2027; it is estimated to grow at a CAGR of 3.2% from 2020 to 2027. Aging population is vastly vulnerable to viral infections as well as chronic conditions. Diabetes in adults generates higher risk of functional...
Saudi Arabia In Vitro Diagnostics (IVD) Market, Forecast by Segments, Applications, End User, Company Analysis In-vitro diagnostics (IVD) plays a significant role in the Saudi Arabia healthcare system by providing accurate diagnosis and prognosis, thus enabling improved monitoring and treatment. Saudi...
The in-vitro diagnostics market in Asia Pacific is expected to grow from US$ 13,729.8 million in 2019 to US$ 20,401.5 million by 2027; it is estimated to grow at a CAGR of 5.1% from 2020 to 2027. Incidence of chronic diseases such as cancers, chronic respiratory diseases, diabetes, and heart disease is growing due to biological risk factors,...
The in-vitro diagnostics market in Europe is expected to grow from US$ 15,973.0 million in 2019 to US$ 22,221.8 million by 2027; it is estimated to grow at a CAGR of 4.2% from 2020 to 2027. The in-vitro diagnostics market has accounted for a significant market share in the healthcare industry during the COVID-19 pandemic. The market growth...
The in-vitro diagnostics market in North America is expected to grow from US$ 26,981.2 million in 2019 to US$ 38,759.6 million by 2027; it is estimated to grow at a CAGR of 4.7% from 2020 to 2027. Aging population is vastly vulnerable to viral infections as well as chronic conditions. For instance, according to the research conducted by American...
The in-vitro diagnostics market in South and Central America is expected to grow from US$ 4,387.7 million in 2019 to US$ 5,820.0 million by 2027; it is estimated to grow at a CAGR of 3.6% from 2020 to 2027. Automation deals with the utilization of various intelligent systems with an aim to perform any operation with minimal human intervention....
The GCC in-vitro diagnostic devices market reached a value of US$ 1,233 Million in 2020. In-vitro diagnostics (IVD) refer to the clinical tests conducted on different bodily samples, such as urine, tissue and blood, to detect diseases and infections. These tests are also employed to monitor the health conditions of...
China In-Vitro Diagnostics (IVD) market is predicted to exceed US$ 21 Billion by 2027. China is a large and fast-growing in vitro diagnostics (IVD) market - in fact, only second to the United States in terms of value. Historically, large multinational companies have dominated IVD market in China; today, domestic companies such as Shanghai...
Reproductive Hormones and Proteins Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Reproductive Hormones and Proteins Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative...
The United States In Vitro Diagnostics (IVD) market is predicted to reach nearly US$ 37 Billion by 2026. In-vitro Diagnostics (IVD) serves a key role in the healthcare value chain by significantly influencing the quality of health outcomes, patient treatment, care and downstream resource requirements. With an aging population, technological...
In Vitro Diagnostics
Cervical Cancer Screening Coverage
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.